The utility of genome‐wide association studies in hepatology

Over the last 4 years, more than 450 genome‐wide association studies (GWAS) have been successfully performed in a variety of human traits, of which approximately 2% relates to the field of hepatology. Whereas the many robust susceptibility gene findings have provided insight into fundamental physiological aspects of the phenotypes that have been studied, the widespread application has also revealed important limitations of the GWAS design. This review aims to systematically summarize both the strengths and the weaknesses of GWAS, as well as underscore important experiences made in model diseases outside the field of hepatology. By reviewing the GWAS performed in hepatology so far on this broader background, extensions and guidelines for the rational application of the study design in hepatology are proposed. (Hepatology 2010)

[1]  S. Kashiwagi,et al.  Contribution of HLA class I and class II alleles to the regulation of antibody production to hepatitis B surface antigen in humans. , 1996, International immunology.

[2]  N Risch,et al.  The Future of Genetic Studies of Complex Human Diseases , 1996, Science.

[3]  K. Weiss,et al.  Linkage disequilibrium mapping of complex disease: fantasy or reality? , 1998, Current opinion in biotechnology.

[4]  J. Nadeau,et al.  Finding Genes That Underlie Complex Traits , 2002, Science.

[5]  S. Liu-Cordero.  Patterns of linkage disequilibrium in the human genome , 2002 .

[6]  C. O'Morain,et al.  CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. , 2002, American journal of human genetics.

[7]  P. Donaldson,et al.  Genetic factors in the pathogenesis of primary biliary cirrhosis. , 2003, Clinics in liver disease.

[8]  Jack Satsangi,et al.  New genes in inflammatory bowel disease: lessons for complex diseases? , 2006, The Lancet.

[9]  E. Carlsson,et al.  Variation in the adiponutrin gene influences its expression and associates with obesity. , 2006, Diabetes.

[10]  D. Reich,et al.  Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.

[11]  A. Morris,et al.  Fine mapping versus replication in whole-genome association studies. , 2007, American journal of human genetics.

[12]  T. Wienker,et al.  Increased gallstone risk in humans conferred by common variant of hepatic ATP‐binding cassette transporter for cholesterol , 2007, Hepatology.

[13]  P. Donnelly,et al.  Replicating genotype–phenotype associations , 2007, Nature.

[14]  Michael Krawczak,et al.  A genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease , 2007, Nature Genetics.

[15]  M. McCarthy,et al.  Genome-wide association studies for complex traits: consensus, uncertainty and challenges , 2008, Nature Reviews Genetics.

[16]  Christopher G. Mathew,et al.  New links to the pathogenesis of Crohn disease provided by genome-wide association scans , 2008, Nature Reviews Genetics.

[17]  A. Morris,et al.  Evaluating the effects of imputation on the power, coverage, and cost efficiency of genome-wide SNP platforms. , 2008, American journal of human genetics.

[18]  L. Naldi,et al.  A European study of HLA-B in Stevens–Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs , 2008, Pharmacogenetics and genomics.

[19]  Nicholas J Schork,et al.  Methods for handling multiple testing. , 2008, Advances in genetics.

[20]  Alexander Pertsemlidis,et al.  Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease , 2008, Nature Genetics.

[21]  Judy H. Cho,et al.  Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease , 2008, Nature Genetics.

[22]  Luigi Ferrucci,et al.  Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes. , 2008, American journal of human genetics.

[23]  Judy H. Cho,et al.  Finding the missing heritability of complex diseases , 2009, Nature.

[24]  Peter Kraft,et al.  Genetic risk prediction--are we there yet? , 2009, The New England journal of medicine.

[25]  Joseph T. Glessner,et al.  From Disease Association to Risk Assessment: An Optimistic View from Genome-Wide Association Studies on Type 1 Diabetes , 2009, PLoS genetics.

[26]  Ming-Huei Chen,et al.  Genome-wide association meta-analysis for total serum bilirubin levels. , 2009, Human molecular genetics.

[27]  Thomas Berg,et al.  IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy , 2009, Nature Genetics.

[28]  A. Zhernakova,et al.  Detecting shared pathogenesis from the shared genetics of immune-related diseases , 2009, Nature Reviews Genetics.

[29]  Common disorders are quantitative traits , 2009, Nature Reviews Genetics.

[30]  R. Plomin,et al.  Common disorders are quantitative traits , 2009, Nature Reviews Genetics.

[31]  John P. A. Ioannidis,et al.  Validating, augmenting and refining genome-wide association signals , 2009, Nature Reviews Genetics.

[32]  M. Daly,et al.  HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin , 2009, Nature Genetics.

[33]  Pauline C Ng,et al.  An agenda for personalized medicine. , 2009, Nature.

[34]  Karen L. Mohlke,et al.  Genetic Risk Prediction — Are We There Yet? , 2009 .

[35]  K. Siminovitch,et al.  Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. , 2009, The New England journal of medicine.

[36]  A. Koike,et al.  Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C , 2009, Nature Genetics.

[37]  D. Clayton.  Prediction and Interaction in Complex Disease Genetics: Experience in Type 1 Diabetes , 2009, PLoS genetics.

[38]  Jacques Fellay,et al.  Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance , 2009, Nature.

[39]  G. Abecasis,et al.  Common variants in the SLCO1B3 locus are associated with bilirubin levels and unconjugated hyperbilirubinemia. , 2009, Human Molecular Genetics.

[40]  F. Collins,et al.  Potential etiologic and functional implications of genome-wide association loci for human diseases and traits , 2009, Proceedings of the National Academy of Sciences.

[41]  J. Hirschhorn.  Genomewide association studies--illuminating biologic pathways. , 2009, The New England journal of medicine.

[42]  David B. Goldstein,et al.  Genetic variation in IL28B and spontaneous clearance of hepatitis C virus , 2009, Nature.

[43]  Y. Kamatani,et al.  A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians , 2009, Nature Genetics.

[44]  David B. Goldstein,et al.  Rare Variants Create Synthetic Genome-Wide Associations , 2010, PLoS biology.

[45]  David Kershenobich,et al.  Variant in PNPLA3 is associated with alcoholic liver disease , 2010, Nature Genetics.

[46]  Nancy R Cook,et al.  Association between a literature-based genetic risk score and cardiovascular events in women. , 2010, JAMA.

[47]  D. Clayton,et al.  Genome-wide association study and meta-analysis finds over 40 loci affect risk of type 1 diabetes , 2009, Nature Genetics.

[48]  T. Karlsen,et al.  Genetics of cholestatic liver disease in 2010 , 2010, Current opinion in gastroenterology.

[49]  C. Wijmenga,et al.  Genome-wide association analysis in primary sclerosing cholangitis. , 2010, Gastroenterology.

[50]  C. Rui.  Genetic variation in IL-28B and spontaneous clearance of hepatitis C virus , 2012 .